Crossject

Crossject combines well known drugs with an innovative mode of injection, its prefilled and single-use needle-free injection system, ZENEO, which can be tailored to deliver drugs intradermally, subcutaneously and intramuscularly. The company’s focus is on products (e.g. adrenaline) for use in emergencies.
Headquarters
Crossject
6 rue Pauline Kergomard,
1000 Dijon
France
Phone / Contact
T: +33 3 80 54 98 50Articles by Crossject
W3 Total Cache is currently running in Pro version Development mode.